Orphinic Scientific

Vasa Therapeutics is a preclinical-stage biopharmaceutical company based in Encinitas, CA. It focuses on discovering and developing therapies for treating vascular diseases such as heart failure, peripheral artery disease, and sarcopenia.

Ambulero, Inc. is a biotechnology company that originated as a spin-out from the University of Miami, dedicated to the advancement of innovative therapies for vascular diseases. The company specializes in the development of cell and gene therapy products, utilizing various cell and synthetic vector technologies to deliver adhesion molecules. This approach aims to enhance the healing of damaged limbs, offering significant improvements over conventional treatment methods. Through its research and development efforts, Ambulero seeks to address critical medical needs in the field of vascular tissue health.